. 2012 Apr 19;2012:176290. doi: 10.1155/2012/176290

Table 1.

Clinical characteristics of the Patient Groups.

Group	Non-FTD	FTD	P value
Positive FTD	0 (1) 0–2	17 (11) 5–20	<0.001^a
Negative FTD	5 (7) 0–9	6 (6) 3–14	0.546^a
SAPS (sum)	23 (16) 8–50	14 (10) 6–26	0.471^b
SANS (sum)	19 (9) 1–34	27 (13) 11–52	0.588^b
GAF	31 (13) 21–51	30 (14) 20–40	0.546^a
Chlorpromazine equivalent in (mg/day)	700 (967) 133–1800	517 (550) 320–1200	0.772^a
Duration of illness (in years)	6 (12) 0.5–17	11 (14) 8–28	0.190^a
Hospital admissions
Number	2 (4) 1–15	6 (9) 1–20	0.142^a
Age at 1st	25 (9) 19–60	26 (11) 15–31	0.222^a

^aMann-Whitney [median (interquartile range) min and max], ^bANOVA [Mean (SD) and range], ^cFischer Exact.